Development of Novel Chitosan Microcapsules for Pulmonary Delivery of Dapsone: Characterization, Aerosol Performance, and In Vivo Toxicity Evaluation

Journal Title: AAPS PharmSciTech - Year 2015, Vol 16, Issue 5

Abstract

Pneumocystis carinii pneumonia (PCP) is a major opportunistic infection that affects patients with human immunodeficiency virus. Although orally administered dapsone leads to high hepatic metabolism, decreasing the therapeutic index and causing severe side effects, this drug is an effective alternative for the treatment of PCP. In this context, microencapsulation for pulmonary administration can offer an alternative to increase the bioavailability of dapsone, reducing its adverse effects. The aim of this work was to develop novel dapsone-loaded chitosan microcapsules intended for deep-lung aerosolized drug delivery. The geometric particle size (D4,3) was approximately 7 μm, the calculated aerodynamic diameter (daero) was approximately 4.5 μm, and the mass median aerodynamic diameter from an Andersen cascade impactor was 4.7 μm. The in vitro dissolution profile showed an efficient dapsone encapsulation, demonstrating the sustained release of the drug. The in vitro deposition (measured by the Andersen cascade impactor) showed an adequate distribution and a high fine particles fraction (FPF = 50%). Scanning electron microscopy of the pulmonary tissues demonstrated an adequate deposition of these particles in the deepest part of the lung. An in vivo toxicity experiment showed the low toxicity of the drug-loaded microcapsules, indicating a protective effect of the microencapsulation process when the particles are microencapsulated. In conclusion, the pulmonary administration of the novel dapsone-loaded microcapsules could be a promising alternative for PCP treatment.

Authors and Affiliations

Manoel Ortiz, Denise Soledade Jornada, Adriana Raffin Pohlmann, Sílvia Stanisçuaski Guterres

Keywords

Related Articles

Fast Tablet Tensile Strength Prediction Based on Non-Invasive Analytics

The online version of this article (doi:10.1208/s12249-014-0104-0) contains supplementary material, which is available to authorized users.

Comparative Pharmacokinetic Study of Mangiferin After Oral Administration of Pure Mangiferin and US Patented Polyherbal Formulation to Rats

The online version of this article (doi:10.1208/s12249-014-0206-8) contains supplementary material, which is available to authorized users.

Relaxation Kinetic Study of Eudragit® NM30D Film Based on Complex Modulus Formalism

This study is aimed at resolving and characterizing the primary (α) and secondary relaxations (β) in Eudragit® NM30D film based on apparent activation energies derived from complex modulus formali...

Statistical Design for Formulation Optimization of Hydrocortisone Butyrate-Loaded PLGA Nanoparticles

The aim of this investigation was to develop hydrocortisone butyrate (HB)-loaded poly(d ,l -lactic-co-glycolic acid) (PLGA) nanoparticles (NP) with ideal encapsulation efficiency (EE), particle size, and drug loading (DL...

A Short Term Quality Control Tool for Biodegradable Microspheres

Accelerated in vitro release testing methodology has been developed as an indicator of product performance to be used as a discriminatory quality control (QC) technique for the release of clinical and commercial batches...

Download PDF file
  • EP ID EP682282
  • DOI  10.1208/s12249-015-0283-3
  • Views 80
  • Downloads 0

How To Cite

Manoel Ortiz, Denise Soledade Jornada, Adriana Raffin Pohlmann, Sílvia Stanisçuaski Guterres (2015). Development of Novel Chitosan Microcapsules for Pulmonary Delivery of Dapsone: Characterization, Aerosol Performance, and In Vivo Toxicity Evaluation. AAPS PharmSciTech, 16(5), -. https://europub.co.uk/articles/-A-682282